Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) (CRRT)
Cytomegalovirus Retinitis Retreatment Trial
Sponsor: Baylor College of Medicine
Listed as NCT00000134, this PHASE3 trial focuses on Acquired Immunodeficiency Syndrome and Cytomegalovirus Retinitis and remains completed. Sponsored by Baylor College of Medicine, it has been updated 8 times since 1992, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Dec 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Icahn School of Medicine at Mount Sinai
- Johns Hopkins Bloomberg School of Public Health
- Johns Hopkins University
- Memorial Sloan Kettering Cancer Center
- National Eye Institute (NEI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- New York Presbyterian Hospital
- New York University
- Northwestern University
- Tulane University School of Medicine
- University of California, Los Angeles
- University of California, San Diego
- University of California, San Francisco
- University of Miami
- University of North Carolina, Chapel Hill
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.